Evidence map›Paper›PMID 35067771›Full record

Observational studyGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2022

Pachychoroid spectrum disease and choriocapillary flow analysis in patients with Cushing disease: an optical coherence tomography angiography study.

Nicola Vito Lassandro, Michele Nicolai, Giorgio Arnaldi, Alessandro Franceschi, Paolo Pelliccioni, Luca Cantini, Rosaria Gesuita, Andrea Faragalli, Cesare Mariotti

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nicola Vito LassandroEye Clinic, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche, via Conca 61, 60126, Ancona, Italy.
Michele NicolaiEye Clinic, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche, via Conca 61, 60126, Ancona, Italy.
Giorgio ArnaldiDivision of Endocrinology, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche, Ancona, Italy.
Alessandro FranceschiEye Clinic, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche, via Conca 61, 60126, Ancona, Italy. a.franceschi.md@gmail.com.ORCID https://orcid.org/0000-0001-8867-4488
Paolo PelliccioniEye Clinic, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche, via Conca 61, 60126, Ancona, Italy.
Luca CantiniClinical Oncology, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche, Ancona, Italy.
Rosaria GesuitaCenter of Epidemiology, Biostatistics and Medical Information Technology, Polytechnic University of Marche, Ancona, Italy.
Andrea FaragalliCenter of Epidemiology, Biostatistics and Medical Information Technology, Polytechnic University of Marche, Ancona, Italy.
Cesare MariottiEye Clinic, AOU Ospedali Riuniti Ancona - Polytechnic University of Marche, via Conca 61, 60126, Ancona, Italy.
Marche Polytechnic University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal thickness (SFCT) and choriocapillary flow using spectral domain OCT (SD-OCT) with the enhanced depth imaging (EDI) and optical coherence tomography angiography (OCT-A).

methodsThirty-two patients with CD and 32 age- and sex-matched healthy volunteers were enrolled in this observational study. All participants had a complete ophthalmic examination including SD-OCT with EDI and OCT-A, and were subjected to the Perceived Stress Scale test (PSS). All patients with CD had hormone test including 24-h urinary-free cortisol (UFC) and plasma adrenocorticotropic hormone (ACTH). We compared SFCT and choriocapillary vessel density (CVD) between the two groups and evaluated the presence of PSD. We investigated the association of hormone level, SFTC, CVD with the presence of CD; the association between the hormone level, SFTC, CVD, the CD disease activity, and duration with the presence of PSD in CD patients; and the association between SFTC and CVD with the hormone level, the CD disease activity, and duration in CD patients.

resultsHigher values of SFCT and CVD were associated with CD (β: 0.028, 95% CI: 0.014; 0.041; β: 0.912, 95%CI: 0.205; 1.62, respectively). Twelve patients with CD (37.5%) reported a PSD in at least one eye, whereas no subject was found in control group (p < 0.001); in particular, 11 CD patients (34%) presented pachychoroid pigment epitheliopathy (PPE) and 1 CD patient (3%) presented polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV/AT1). In patients with CD, a significant positive association between SFCT and PSD was found (β: 0.010, 95% CI 0.001; 0.019).

conclusionA chronic state of hypercortisolism may have direct implications on the choroid. Patients with CD had higher SFCT values and a significant change in the choriocapillary flow compared to healthy controls. Moreover, PSD was observed only in CD patients.

Indexed as

Pituitary ACTH HypersecretionVascular DiseasesChoroidFluorescein AngiographyHormonesHumansRetrospective StudiesTomography, Optical CoherenceHormonesChoroidCortisolCushingMultimodal imagingNeovasculopathyPachychoroid

Identifiers

PMID35067771
OpenAlexW4207016950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.